<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7-ijms-19-01312">
 <label>7.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fellner</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Barhum</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Angel</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Perets</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Steiner</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Offen</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Lev</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Toll-like receptor-4 inhibitor tak-242 attenuates motor dysfunction and spinal cord pathology in an amyotrophic lateral sclerosis mouse model</article-title>
  <source>Int. J. Mol. Sci.</source>
  <year>2017</year>
  <volume>18</volume>
  <elocation-id>1666</elocation-id>
  <pub-id pub-id-type="doi">10.3390/ijms18081666</pub-id>
  <?supplied-pmid 28763002?>
  <pub-id pub-id-type="pmid">28763002</pub-id>
 </element-citation>
</ref>
